- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
Articles on Mylan Laboratories Inc. (MYL)
by latest | most commented
-
Stocks with the Highest Short Interest
-
Dealmaking Sweeps the Biotech Sector
-
Healthcare: Branded Pharma Out, Diagnostics / Generics In
-
Generic Players Continue to Impress in H1
-
Watson Pharmaceuticals Says to Look Ahead to June 2009 Earnings
-
Indian Markets Tuesday Wrap-Up: Downward Journey Continues
-
10 New Stock Indexes for Tracking Healthcare Trends
-
Pharma Announces $80B Reduction: Who Wins?
-
Stryker Corp Looks Good for Health Care Rebound
-
Merck Short Base Rising
-
Galleon Bets Heavily on the S&P 500
-
Health Care Trends Part 2: M&A, Generic Competition, CROs
-
Caraco Pharma Poised for a Turnaround
-
Is Mylan Short Base Rising over Uncertainties in Healthcare?
-
20 'Bathwater Babies' and 20 'Dogs with Fleas' Stocks for the Week
-
Wall Street Breakfast: Must-Know News
-
Stocks Closest to 52-Week Highs
-
Mid-April Short Interest
-
A Look at D.E. Shaw's Q408 Holdings: Just for Fun
-
Impax Labs: Strong Balance Sheet, Focused R&D
-
Galleon's Q408: SPY Pays Off Alongside Reduced Equity Positions
-
S&P 500 Stocks Furthest Above 200-Day Moving Averages
-
The Week Ahead: Damage Control
-
15 Long Ideas for Buying on Strength
-
Moore Capital Investments: Theme Is Economic Recovery
-
S&P 500 Best and Worst Performers, Q1 2009 (Excluding Financials)
-
Biotech Dip: Sector Weakness, or Buying Opportunity?
-
Hedge Fund Portfolio Tracking: Peter Thiel's Clarium Capital, Q4 2008
-
Largest CEO Buys - Monster Worldwide, GLG Partners, Mylan and Rockwood Holdings
-
Biotech Going Generic Like Big Pharma?
-
Sinking or Rising: Top 10 S&P Winners and Losers, Year-to-Date
-
Best and Worst Performing S&P 500 Stocks Since 2/12
-
Hedge Fund Portfolio Tracking: Soros Fund Management (George Soros), Q4 2008
-
Mylan: Showing Up Doubters
-
Wall Street Breakfast: Must-Know News
-
Goodwill Hunting: Beware Potential Asset Impairment Charges
-
Hi-Tech Pharmacal: High Growth at a Value Price
-
Forest Laboratories: Perhaps the Next Consolidator?
-
Six Sectors Presenting Opportunities as Obama Takes Office
-
Best Performing Stocks Since Election Day
-
Hedge Fund Portfolio Tracking: D.E. Shaw & Co (David E. Shaw), Q3 2008